Back to MW MARSHALL WACE, LLP

NRXPNRXP
5 quarters

Position history for MWMARSHALL WACE, LLP's holdings in NRX PHARMACEUTICALS INC

MARSHALL WACE, LLP holds 194,580 shares of NRXP (NRX PHARMACEUTICALS INC), worth $795,831 as of 2026-Q2. This is a new position. NRXP represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$795,831

Current Shares

194,580

Total Value Change

+$613,205

Total Shares Change

+105,494

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
194,580
-
$795,8310.0%$4.09
34
2025-Q4
Exited
0
-100.0%
$00.0%$2.63
0
2025-Q3
Increased
189,136
+466.6%
$624,1500.0%$3.25
39
2025-Q2
Decreased
33,384
-62.5%
$108,8320.0%$3.42
0
2025-Q1
New
89,086
-
$182,6260.0%$2.03
31

Other major holders of NRXP: VANGUARD CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, BALYASNY ASSET MANAGEMENT L.P., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used